Patents by Inventor Wolfgang Schuler

Wolfgang Schuler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10766931
    Abstract: The present invention relates to compositions and methods for the prevention and treatment of Borrelia infection. Particularly, the present invention relates to a polypeptide comprising a hybrid C-terminal fragment of an outer surface protein A (OspA), a nucleic acid coding the same, an antibody specifically binding the same, a pharmaceutical composition (particularly for use as a medicament or in a method of treating or preventing a Borrelia infection) comprising the polypeptide and/or the nucleic acid and/or the antibody, a method of treating or preventing a Borrelia infection and a method of immunizing a subject.
    Type: Grant
    Filed: April 4, 2018
    Date of Patent: September 8, 2020
    Assignee: Valneva Austria GmbH
    Inventors: Urban Lundberg, Wolfgang Schüler
  • Publication number: 20200239525
    Abstract: The present invention relates to a polypeptide comprising a mutant fragment of an outer surface protein A (OspA), a nucleic acid coding the same, a pharmaceutical composition (particularly for use as a medicament of in a method of treating or preventing a Borrelia infection) comprising the polypeptide and/or the nucleic acid, a method of treating or preventing a Borrelia infection and a method of immunizing a subject.
    Type: Application
    Filed: December 4, 2019
    Publication date: July 30, 2020
    Applicant: Valneva Austria GmbH
    Inventors: Pär Comstedt, Urban Lundberg, Andreas Meinke, Markus Hanner, Wolfgang Schüler, Benjamin Wizel, Christoph Reinisch, Brigitte Grohmann, Robert Schlegl
  • Publication number: 20200122160
    Abstract: The present invention relates to a process for separating at least one first material from a mixture comprising this at least one first material, at least one second material and at least one third material, which comprises at least the following steps: (A) providing a mixture comprising at least one first material, at least one second material, at least one third material and at least one hydrocarbon in an amount of more than 0.
    Type: Application
    Filed: August 2, 2018
    Publication date: April 23, 2020
    Inventors: David Johann GILBERT, Wolfgang ROHDE, Michael MENTGES, Rodrigo Enrique MUNIZAGA, Oliver KUHN, Bernhard SCHULER
  • Patent number: 10557291
    Abstract: A method for controlling a closing process of a vehicle wing moving from a known start position into an end position representing as closed, position of the vehicle wing and a corresponding closing system for performing the method, When the start position is reached, the closing process of the vehicle wing is started for a prescribed short first time period, and then interrupted for a prescribed second time period in order to warn users or third parties of the imminent closing process of the vehicle wing.
    Type: Grant
    Filed: December 10, 2009
    Date of Patent: February 11, 2020
    Assignee: Daimler AG
    Inventors: Roland Breitner, Hans Deischl, Martin Lindmayer, Wolfgang Much, Dieter Scheunert, Eckart Schuler, Falk Zeidler
  • Patent number: 10544194
    Abstract: The present invention relates to a polypeptide comprising a mutant fragment of an outer surface protein A (OspA), a nucleic acid coding the same, a pharmaceutical composition (particularly for use as a medicament of in a method of treating or preventing a Borrelia infection) comprising the polypeptide and/or the nucleic acid, a method of treating or preventing a Borrelia infection and a method of immunizing a subject.
    Type: Grant
    Filed: September 22, 2016
    Date of Patent: January 28, 2020
    Assignee: Valneva Austria GmbH
    Inventors: Pär Comstedt, Urban Lundberg, Andreas Meinke, Markus Hanner, Wolfgang Schüler, Benjamin Wizel, Christoph Reinisch, Brigitte Grohmann, Robert Schlegl
  • Publication number: 20180362593
    Abstract: The present invention relates to compositions and methods for the prevention and treatment of Borrelia infection. Particularly, the present invention relates to a polypeptide comprising a hybrid C-terminal fragment of an outer surface protein A (OspA), a nucleic acid coding the same, an antibody specifically binding the same, a pharmaceutical composition (particularly for use as a medicament or in a method of treating or preventing a Borrelia infection) comprising the polypeptide and/or the nucleic acid and/or the antibody, a method of treating or preventing a Borrelia infection and a method of immunizing a subject.
    Type: Application
    Filed: April 4, 2018
    Publication date: December 20, 2018
    Applicant: Valneva Austria GmbH
    Inventors: Urban Lundberg, Wolfgang Schüler
  • Publication number: 20180327460
    Abstract: The present invention relates to a polypeptide comprising a mutant fragment of an outer surface protein A (OspA), a nucleic acid coding the same, a pharmaceutical composition (particularly for use as a medicament of in a method of treating or preventing a Borrelia infection) comprising the polypeptide and/or the nucleic acid, a method of treating or preventing a Borrelia infection and a method of immunizing a subject.
    Type: Application
    Filed: February 27, 2018
    Publication date: November 15, 2018
    Applicant: Valneva Austria GmbH
    Inventors: Pär Comstedt, Markus Hanner, Urban Lundberg, Andreas Meinke, Wolfgang Schüler, Benjamin Wizel
  • Patent number: 9975927
    Abstract: The present invention relates to compositions and methods for the prevention and treatment of Borrelia infection. Particularly, the present invention relates to a polypeptide comprising a hybrid C-terminal fragment of an outer surface protein A (OspA), a nucleic acid coding the same, an antibody specifically binding the same, a pharmaceutical composition (particularly for use as a medicament or in a method of treating or preventing a Borrelia infection) comprising the polypeptide and/or the nucleic acid and/or the antibody, a method of treating or preventing a Borrelia infection and a method of immunizing a subject.
    Type: Grant
    Filed: January 9, 2015
    Date of Patent: May 22, 2018
    Assignee: Valneva Austria GmbH
    Inventors: Urban Lundberg, Wolfgang Schüler
  • Patent number: 9926343
    Abstract: The present invention relates to a polypeptide comprising a mutant fragment of an outer surface protein A (OspA), a nucleic acid coding the same, a pharmaceutical composition (particularly for use as a medicament of in a method of treating or preventing a Borrelia infection) comprising the polypeptide and/or the nucleic acid, a method of treating or preventing a Borrelia infection and a method of immunizing a subject.
    Type: Grant
    Filed: September 16, 2016
    Date of Patent: March 27, 2018
    Assignee: Valneva Austria GmbH
    Inventors: Pär Comstedt, Markus Hanner, Urban Lundberg, Andreas Meinke, Wolfgang Schüler, Benjamin Wizel
  • Publication number: 20170107263
    Abstract: The present invention relates to a polypeptide comprising a mutant fragment of an outer surface protein A (OspA), a nucleic acid coding the same, a pharmaceutical composition (particularly for use as a medicament of in a method of treating or preventing a Borrelia infection) comprising the polypeptide and/or the nucleic acid, a method of treating or preventing a Borrelia infection and a method of immunizing a subject.
    Type: Application
    Filed: September 16, 2016
    Publication date: April 20, 2017
    Applicant: Valneva Austria GmbH
    Inventors: Pär Comstedt, Markus Hanner, Urban Lundberg, Andreas Meinke, Wolfgang Schüler, Benjamin Wizel
  • Publication number: 20170101446
    Abstract: The present invention relates to a polypeptide comprising a mutant fragment of an outer surface protein A (OspA), a nucleic acid coding the same, a pharmaceutical composition (particularly for use as a medicament of in a method of treating or preventing a Borrelia infection) comprising the polypeptide and/or the nucleic acid, a method of treating or preventing a Borrelia infection and a method of immunizing a subject.
    Type: Application
    Filed: September 22, 2016
    Publication date: April 13, 2017
    Applicant: Valneva Austria GmbH
    Inventors: Pär Comstedt, Urban Lundberg, Andreas Meinke, Markus Hanner, Wolfgang Schüler, Benjamin Wizel, Christoph Reinisch, Brigitte Grohmann, Robert Schlegl
  • Publication number: 20160333056
    Abstract: The present invention relates to compositions and methods for the prevention and treatment of Borrelia infection. Particularly, the present invention relates to a polypeptide comprising a hybrid C-terminal fragment of an outer surface protein A (OspA), a nucleic acid coding the same, an antibody specifically binding the same, a pharmaceutical composition (particularly for use as a medicament or in a method of treating or preventing a Borrelia infection) comprising the polypeptide and/or the nucleic acid and/or the antibody, a method of treating or preventing a Borrelia infection and a method of immunizing a subject.
    Type: Application
    Filed: January 9, 2015
    Publication date: November 17, 2016
    Applicant: Valneva Austria GmbH
    Inventors: Urban Lundberg, Wolfgang Schüler
  • Publication number: 20150250865
    Abstract: The present invention relates to a polypeptide comprising a mutant fragment of an outer surface protein A (OspA), a nucleic acid coding the same, a pharmaceutical composition (particularly for use as a medicament of in a method of treating or preventing a Borrelia infection) comprising the polypeptide and/or the nucleic acid, a method of treating or preventing a Borrelia infection and a method of immunizing a subject.
    Type: Application
    Filed: February 17, 2015
    Publication date: September 10, 2015
    Applicant: Valneva Austria GmbH
    Inventors: Pär Comstedt, Markus Hanner, Urban Lundberg, Andreas Meinke, Wolfgang Schüler, Benjamin Wizel
  • Publication number: 20150232517
    Abstract: The present invention relates to a polypeptide comprising a mutant fragment of an outer surface protein A (OspA), a nucleic acid coding the same, a pharmaceutical composition (particularly for use as a medicament of in a method of treating or preventing a Borrelia infection) comprising the polypeptide and/or the nucleic acid, a method of treating or preventing a Borrelia infection and a method of immunizing a subject.
    Type: Application
    Filed: July 8, 2013
    Publication date: August 20, 2015
    Inventors: Pär Comstedt, Urban Lundberg, Andreas Meinke, Markus Hanner, Wolfgang Schüler, Benjamin Wizel, Christoph Reinisch, Brigitte Grohmann, Robert Schlegl
  • Patent number: 6072119
    Abstract: The invention relates to a filtering device with a filter housing which can accept a filter mat, is covered with a lamella grid on the outlet side and is fitted in an aperture in a mounting wall. RF screening is attained without altering the structure of the filtering device in that the surface of the filter housing is electrically conductive and inserted in the aperture in the mounting plate via an electrically conductive contact frame. The contact frame is electrically connected to the filter housing and the aperture in the mounting plate and there is an electrically conductive screening grid inserted or mounted in the filter housing or between the latter and a fan which can be linked thereto.
    Type: Grant
    Filed: February 10, 1998
    Date of Patent: June 6, 2000
    Assignee: Rittal-Werk Rudolf Loh GmbH & Co. KG
    Inventors: Walter Nicolai, Adam Pawlowski, Wolfgang Schuler, Heinrich Strackbein
  • Patent number: 4583734
    Abstract: A tennis racket having a head portion, handle portion and a shaft portion connecting the head portion to the handle portion. The shaft portion includes an arc which extends perpendicular to the plane defined by the head portion. Alternatively, a portion of the shaft has a thickness that is reduced in comparison to the rest of the shaft. In both embodiments, a filamentary traction element can be used to bridge the corresponding arc or reduced portion.
    Type: Grant
    Filed: April 10, 1985
    Date of Patent: April 22, 1986
    Inventors: Ulrich Pawlicki, Wolfgang Schuler
  • Patent number: 4565371
    Abstract: A tennis racket having a handle which is constructed so that the racket will flex more readily when the ball strikes one surface of the racket strings than when the ball strikes the opposite surface of the strings. This difference in flexibility enables the racket user to selectively return a soft or a hard stroke by turning the racket through 180.degree.. The difference in handle flexibility can be obtained by (1) making the handle assymetric in cross section as in FIG. 1, or (2) making one longitudinal side of the handle of a material of different elasticity than the opposite longitudinal side, or (3) providing a bend in the handle as shown in FIG. 3 and FIG. 4.
    Type: Grant
    Filed: March 29, 1984
    Date of Patent: January 21, 1986
    Inventors: Ulrich Pawlicki, Wolfgang Schuler
  • Patent number: D375942
    Type: Grant
    Filed: April 11, 1990
    Date of Patent: November 26, 1996
    Inventors: Roger Fursier, Claus-Dieter Bovermann, Norbert Muller, Wolfgang Schuler